Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 249

Similar articles for PubMed (Select 18521110)

1.

Cardiovascular effects of medroxyprogesterone acetate and progesterone: a case of mistaken identity?

Hermsmeyer RK, Thompson TL, Pohost GM, Kaski JC.

Nat Clin Pract Cardiovasc Med. 2008 Jul;5(7):387-95. doi: 10.1038/ncpcardio1234. Epub 2008 Jun 3. Review.

PMID:
18521110
2.

Alternative hormone replacement regimens: is there a need for further clinical trials?

Welty FK.

Curr Opin Lipidol. 2003 Dec;14(6):585-91. Review.

PMID:
14624135
3.

Preserving cardiovascular benefits of hormone replacement therapy.

Bush TL.

J Reprod Med. 2000 Mar;45(3 Suppl):259-73. Review.

PMID:
10756507
4.

Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.

L'hermite M, Simoncini T, Fuller S, Genazzani AR.

Maturitas. 2008 Jul-Aug;60(3-4):185-201. doi: 10.1016/j.maturitas.2008.07.007. Epub 2008 Sep 5. Review.

PMID:
18775609
5.

Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.

Wood CE, Register TC, Lees CJ, Chen H, Kimrey S, Cline JM.

Breast Cancer Res Treat. 2007 Jan;101(2):125-34.

PMID:
16841178
6.

Postmenopausal hormone use for cardioprotection: what we know and what we must learn.

Wenger NK.

Curr Opin Cardiol. 1999 Jul;14(4):292-7. Review.

PMID:
10448608
8.

The Women's Health Initiative estrogen plus progestin trial: the study and how it changes our practice.

Hendrix SL.

J Am Osteopath Assoc. 2003 Feb;103(2 Suppl 2):S3-5. No abstract available.

PMID:
12625631
9.

Progestins and cardiovascular risk markers.

Sitruk-Ware R.

Steroids. 2000 Oct-Nov;65(10-11):651-8. Review.

PMID:
11108872
10.

Postmenopausal hormone replacement therapy and plasma lipoproteins.

Taskinen MR.

J Intern Med. 1995 Nov;238(5):385-7. No abstract available.

PMID:
7595177
11.

The Heart and Estrogen/Progestin Replacement Study (HERS) in perspective--results not very surprising.

Naessen T.

Acta Obstet Gynecol Scand. 2000 Dec;79(12):1037-41. No abstract available.

PMID:
11130083
12.

Why a consensus conference on hormone replacement therapy and the cardiovascular system?

Benagiano G, Farris M.

Maturitas. 2004 Apr 15;47(4):245-53. Review.

PMID:
15063475
14.

[Menopausal hormone therapy and cardiovascular disease].

Wenger NK.

Rev Esp Cardiol. 2006 Oct;59(10):1058-69. Review. Spanish.

15.

[Effects of hormone replacement therapy in menopause on cardiovascular risk. Need for a European study].

Kuttenn F, Gerson M, de Lignères B.

Presse Med. 2002 Mar 16;31(10):468-75. French.

PMID:
11933751
18.

Hormone therapy and the cardiovascular system: the critical role of progestins.

Sitruk-Ware RL.

Climacteric. 2003 Oct;6 Suppl 3:21-8. Review.

PMID:
15018245
19.

Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.

Rosano GM, Maffei S, Andreassi MG, Vitale C, Vassalle C, Gambacciani M, Stramba-Badiale M, Mercuro G.

J Cardiovasc Med (Hagerstown). 2009 Jan;10(1):85-92. doi: 10.2459/JCM.0b013e328313e979.

PMID:
19145119
20.

The action of ovarian hormones in cardiovascular disease.

Medina RA, Aranda E, Verdugo C, Kato S, Owen GI.

Biol Res. 2003;36(3-4):325-41. Review.

PMID:
14631866
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk